BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33487576)

  • 1. Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Fidelity of Diagnosis Using WHO Criteria.
    Fairchild A; McCall CM; Oyekunle T; Niedzwiecki D; Champ C; McKinney M; Kelsey CR
    Clin Lymphoma Myeloma Leuk; 2021 May; 21(5):e464-e469. PubMed ID: 33487576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Mediastinal B-Cell Lymphoma in Children and Young Adults.
    Forlenza CJ; Chadburn A; Giulino-Roth L
    J Natl Compr Canc Netw; 2023 Mar; 21(3):323-330. PubMed ID: 36898366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary mediastinal lymphomas, their morphological features and comparative evaluation.
    Aggarwal R; Rao S; Dhawan S; Bhalla S; Kumar A; Chopra P
    Lung India; 2017; 34(1):19-24. PubMed ID: 28144055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study between primary mediastinal B-cell lymphoma and non-mediastinal diffuse large B-cell lymphoma by immunoglobulin gene rearrangement and Epstein-Barr virus infection detection].
    Zhong DR; Ling Q; Shi XH; Liang ZY; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):361-5. PubMed ID: 22932401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary mediastinal lymphoma: diagnosis and treatment options.
    Martelli M; Di Rocco A; Russo E; Perrone S; Foà R
    Expert Rev Hematol; 2015 Apr; 8(2):173-86. PubMed ID: 25537750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
    Savage KJ; Al-Rajhi N; Voss N; Paltiel C; Klasa R; Gascoyne RD; Connors JM
    Ann Oncol; 2006 Jan; 17(1):123-30. PubMed ID: 16236753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Mediastinal B-Cell Lymphoma: A 2021 Update on Genetics, Diagnosis, and Novel Therapeutics.
    Ahmed Z; Afridi SS; Shahid Z; Zamani Z; Rehman S; Aiman W; Khan M; Mir MA; Awan FT; Anwer F; Iftikhar R
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e865-e875. PubMed ID: 34330673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis.
    Shah NN; Szabo A; Huntington SF; Epperla N; Reddy N; Ganguly S; Vose J; Obiozor C; Faruqi F; Kovach AE; Costa LJ; Xavier AC; Okal R; Kanate AS; Ghosh N; Kharfan-Dabaja MA; Strelec L; Hamadani M; Fenske TS; Calzada O; Cohen JB; Chavez J; Svoboda J
    Br J Haematol; 2018 Feb; 180(4):534-544. PubMed ID: 29265182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma.
    Kim HJ; Kim HK; Park G; Min SK; Cha HJ; Lee H; Choi SJ; Na HY; Choe JY; Kim JE
    Diagn Pathol; 2019 Dec; 14(1):133. PubMed ID: 31831043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.
    Giulino-Roth L; O'Donohue T; Chen Z; Bartlett NL; LaCasce A; Martin-Doyle W; Barth MJ; Davies K; Blum KA; Christian B; Casulo C; Smith SM; Godfrey J; Termuhlen A; Oberley MJ; Alexander S; Weitzman S; Appel B; Mizukawa B; Svoboda J; Afify Z; Pauly M; Dave H; Gardner R; Stephens DM; Zeitler WA; Forlenza C; Levine J; Williams ME; Sima JL; Bollard CM; Leonard JP
    Br J Haematol; 2017 Dec; 179(5):739-747. PubMed ID: 29082519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic study of 40 cases of mediastinal tumours of haematopoietic and lymphoid tissues].
    Chen DB; Wang Y; Song QJ; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):376-81. PubMed ID: 22932404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience.
    Jain H; Kapoor A; Sengar M; Chanana R; Menon H; Sridhar E; Laskar S; Agarwal A; Shastri J; Khanna N; Rangarajan V; Bagal B; Thorat J; Shet T; Gujral S
    Indian J Hematol Blood Transfus; 2021 Jul; 37(3):379-385. PubMed ID: 34267455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary mediastinal large B-cell lymphoma.
    Savage KJ
    Blood; 2022 Sep; 140(9):955-970. PubMed ID: 34496020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
    Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
    Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediastinal Gray Zone Lymphoma: A Wider Category Than We Think?
    Verma A; Shet T; Epari S; Gupta M; Gujral S; Khanna N; Laskar S; Sengar M; Arora B; Menon H; Banavali S
    Int J Surg Pathol; 2016 Aug; 24(5):382-93. PubMed ID: 26957476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma.
    Chan EHL; Koh LP; Lee J; De Mel S; Jeyasekharan A; Liu X; Tang T; Lim ST; Tao M; Quek R; Farid Bin Harunal Ras M; Lee YS; Diong C; Tan D; Kim SJ; Chee YL; Poon LMM
    Cancer Med; 2019 Aug; 8(10):4626-4632. PubMed ID: 31264808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study.
    Chiappella A; Casadei B; Chiusolo P; Di Rocco A; Ljevar S; Magni M; Angelillo P; Barbui AM; Cutini I; Dodero A; Bonifazi F; Tisi MC; Bramanti S; Musso M; Farina M; Martino M; Novo M; Grillo G; Patriarca F; Zacchi G; Krampera M; Pennisi M; Galli E; Martelli M; Ferreri AJM; Ferrari S; Saccardi R; Bermema A; Guidetti A; Miceli R; Zinzani PL; Corradini P
    Leukemia; 2024 May; 38(5):1107-1114. PubMed ID: 38459167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up.
    Zhou H; Xu-Monette ZY; Xiao L; Strati P; Hagemeister FB; He Y; Chen H; Li Y; Manyam GC; Li Y; Montes-Moreno S; Piris MA; Young KH
    Blood Cancer J; 2020 May; 10(5):49. PubMed ID: 32366834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical Characteristics and Prognosis of 56 Lymphoma Patients with Mediastinal Masses].
    Yu H; Wang L; Zhu HY; Wu W; Liang JH; Yin H; Fan L; Li JY; Xu W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):495-499. PubMed ID: 32319385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary mediastinal (thymic) large B-cell lymphoma: a short review with brief discussion of mediastinal gray zone lymphoma.
    Hutchinson CB; Wang E
    Arch Pathol Lab Med; 2011 Mar; 135(3):394-8. PubMed ID: 21366467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.